✦ LIBER ✦

The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease

✍ Scribed by Shanware, Naval P.; Bray, Kevin; Abraham, Robert T.

Book ID: 118239848
Publisher: Annual Reviews
Year: 2013
Tongue: English
Weight: 615 KB
Volume: 53
Category: Article
ISSN: 0362-1642
DOI: 10.1146/annurev-pharmtox-010611-134717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autophagy: A housekeeper in cardiorenal

Autophagy: A housekeeper in cardiorenal metabolic health and disease

✍ Jia, Guanghong; Sowers, James R. 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Autophagy in Health and Disease || Molec

Autophagy in Health and Disease || Molecular Machinery and Genetics of the Autophagy Pathway

✍ Herr, Deron 📂 Article 📅 2013 🏛 Elsevier ⚖ 614 KB

Autophagy in Health and Disease: A Doubl

Autophagy in Health and Disease: A Double-Edged Sword

✍ Shintani, T. 📂 Article 📅 2004 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 426 KB

Autophagy in health and disease. 2. Regu

Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications

✍ Czaja, M. J. 📂 Article 📅 2010 🏛 The American Physiological Society 🌐 English ⚖ 193 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 346 || More Than Just Kinases: The Scaffolding Function of PI3K

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg ⚖ 512 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Phosphoinositide 3-kinase in Health and Disease Volume 347 || From the Bench to the Bed Side: PI3K Pathway Inhibitors in Clinical Development

✍ Rommel, Christian; Vanhaesebroeck, Bart; Vogt, Peter K. 📂 Article 📅 2010 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 377 KB

PI3K has become a very intense area of research, with over 2000 publications on PI3K in PubMed for 2009 alone. The expectations for a therapeutic impact of intervention with PI3K activity are high, and progress in the clinical arena is being monitored by many. However, targeted therapies almost inva